Beta Bionics (BBNX) Non-Current Deffered Revenue (2023 - 2026)

Beta Bionics has disclosed Non-Current Deffered Revenue across 4 years of filings, most recently posting $3.4 million for Q1 2026.

• Non-Current Deffered Revenue for Q1 2026 came in at $3.4 million, up 43.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.4 million (up 43.78% YoY), and the FY2025 annual result was $3.3 million, up 77.26% from the prior year.
• Non-Current Deffered Revenue came in at $3.4 million for Q1 2026 at Beta Bionics, up from $3.3 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $3.4 million in Q1 2026 to a low of $255000.0 in Q4 2023.
• The 4-year median for Non-Current Deffered Revenue is $2.7 million (2025), against an average of $2.4 million.
• Across the five-year window, Non-Current Deffered Revenue jumped 629.41% in 2024 and jumped 43.78% in 2026, its largest moves.
• Beta Bionics' Non-Current Deffered Revenue stood at $255000.0 in 2023, then surged by 629.41% to $1.9 million in 2024, then surged by 77.26% to $3.3 million in 2025, then rose by 1.61% to $3.4 million in 2026.
• The last three Non-Current Deffered Revenue figures came in at $3.4 million (Q1 2026), $3.3 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.